Radboud University Medical Center

🇳🇱Netherlands

Country: 🇳🇱Netherlands

Ownership: Private

Established: 1951-01-01

Employees: -

Market Cap: -

Website: http://www.radboudumc.nl

Clinical Trials

Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease

Phase 2

Completed

Conditions: Polycystic Liver Disease
Polycystic Kidney, Autosomal Dominant

Interventions: Drug: Ursodeoxycholic Acid

First Posted Date: 2013-12-27

Last Posted Date: 2021-09-23

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 34

Registration Number: NCT02021110

Locations: 🇳🇱
Radboud University Medical Centre Nijmegen, Nijmegen, Gelderland, Netherlands
🇪🇸
Donostia University Hospital, San Sebastian, Spain
🇳🇱
Academic Medical Centre Amsterdam, Amsterdam, Netherlands

Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer

Phase 2

Completed

Conditions: Metastatic Clear Cell Renal Cell Carcinoma

Interventions: Drug: Lu-177-DOTA-girentuximab

First Posted Date: 2013-12-05

Last Posted Date: 2015-08-13

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 14

Registration Number: NCT02002312

Locations: 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands

Ticagrelor and Adenosine

Phase 4

Completed

Conditions: Healthy

Interventions: Drug: Ticagrelor 180 mg single dose
Drug: Placebo

First Posted Date: 2013-11-27

Last Posted Date: 2014-01-10

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 14

Registration Number: NCT01996735

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands

Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS

Completed

Conditions: Sarcoma, Soft Tissue

Interventions: Drug: Pazopanib

First Posted Date: 2013-11-27

Last Posted Date: 2017-12-19

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 22

Registration Number: NCT01995981

Locations: 🇳🇱
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
🇬🇧
Royal Marsden Hospital, London, United Kingdom

Pharmacokinetic Drug-drug Interaction Study Between RaltEgravir and CITALopram in Healthy Subjects (RECITAL).

Phase 1

Completed

Conditions: HIV
Depression

Interventions: Drug: raltegravir
Drug: citalopram

First Posted Date: 2013-11-08

Last Posted Date: 2020-10-19

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 24

Registration Number: NCT01978782

Locations: 🇳🇱
CRCN Radboud university medical center, Nijmegen, Netherlands

Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α

Phase 1

Completed

Conditions: Hyperoxia
Hypoxia
Normoxia

Interventions: Drug: Lipopolysaccharide

First Posted Date: 2013-11-07

Last Posted Date: 2015-05-20

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 30

Registration Number: NCT01978158

Locations: 🇳🇱
Intensive Care Medicine, Nijmegen, Gelderland, Netherlands

Primary Hyperaldosteronism and Ischemia-reperfusion Injury

Not Applicable

Completed

Conditions: Primary Hyperaldosteronism

Interventions: Procedure: forearm ischemia and reperfusion

First Posted Date: 2013-11-07

Last Posted Date: 2017-10-12

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 40

Registration Number: NCT01978132

Locations: 🇳🇱
Radboud University Medical Centre, Nijmegen, Gelderland, Netherlands

Prediction of Everolimus-induced Interstitial Lung Disease

Completed

Conditions: Breast Neoplasms

First Posted Date: 2013-11-07

Last Posted Date: 2018-04-12

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 27

Registration Number: NCT01978171

Locations: 🇳🇱
Antonius Ziekenhuis, Nieuwegein, Netherlands
🇳🇱
Radboud university medical center, Nijmegen, Netherlands

Influence of Exceptional Patient Characteristics on Everolimus Exposure

Phase 4

Completed

Conditions: Breast Neoplasms

Interventions: Drug: everolimus dose escalation

First Posted Date: 2013-09-24

Last Posted Date: 2018-12-07

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 56

Registration Number: NCT01948960

Locations: 🇳🇱
Maasziekenhuis Pantein, Boxmeer, Netherlands
🇳🇱
Maastricht University Medical Center, Maastricht, Netherlands
🇳🇱
St. Antonius Ziekenhuis, Nieuwegein, Netherlands

and more 4 locations

Psychosomatic Therapy, Feasibility and Cost Analysis

Not Applicable

Completed

Conditions: Psychosomatic Therapy
Medically Unexplained Symptoms

Interventions: Other: care as usual
Other: Psychosomatic therapy

First Posted Date: 2013-09-05

Last Posted Date: 2015-09-04

Lead Sponsor: Radboud University Medical Center

Target Recruit Count: 42

Registration Number: NCT01935258

Locations: 🇳🇱
General Practitioner, Kleissen, Haaksbergen, Overijssel, Netherlands
🇳🇱
General Practitioner, Van Rijn, Vriezenveen, Overijssel, Netherlands
🇳🇱
D.J. Jansen, Julianadorp, Netherlands

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy